Sclerostin inhibition for osteoporosis--a new approach

N Engl J Med. 2014 Jan 30;370(5):476-7. doi: 10.1056/NEJMe1315500. Epub 2014 Jan 1.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Antibodies, Monoclonal / administration & dosage*
  • Bone Density / drug effects*
  • Bone Density Conservation Agents / administration & dosage*
  • Bone Remodeling / drug effects*
  • Female
  • Humans
  • Osteoporosis, Postmenopausal / drug therapy*

Substances

  • Antibodies, Monoclonal
  • Bone Density Conservation Agents
  • romosozumab